TNAX Biopharma Company
![](/files/companies/TNAX%20Biopharma.jpeg)
TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.
Founded Date:
2018
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Industry:
PharmTech
Technology:
Anti-infective Drugs
Headquarters:
Asia-Pacific (APAC)
Funding Status:
Early Stage Venture